Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Ordinary Share $0.00001 par value
-
Shares outstanding
-
50,588,235
-
Total 13F shares
-
47,402,456
-
Share change
-
-390,668
-
Total reported value
-
$1,548,591,468
-
Put/Call ratio
-
0%
-
Price per share
-
$32.67
-
Number of holders
-
90
-
Value change
-
+$9,259,415
-
Number of buys
-
48
-
Number of sells
-
30
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) as of Q3 2018
As of 30 Sep 2018,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,402,456 shares.
The largest 10 holders included
Woodford Investment Management Ltd, BAUPOST GROUP LLC/MA, FMR LLC, BlackRock Inc., Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, STATE STREET CORP, NORGES BANK, and Consonance Capital Management LP.
This page lists
90
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.